Shanghai Pharma

Forecast & Rating7 analysts currently cover Shanghai Pharma, with about 57.1% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥20.04, about 24.3% upside from the current price of ¥16.13. Price targets range from ¥12.20 to ¥23.90 — a wide spread, showing clear disagreement over just how much Shanghai Pharma can rise. Historically, about 80.5% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Shanghai Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Nov 12, 2026; for reference only and not investment advice.